Related Experiment Video
Updated: May 5, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Regulation of with-no-lysine kinase signaling by Kelch-like proteins
Shinichi Uchida1, Eisei Sohara, Tatemitsu Rai
1Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
Abstract:
In 2001, with-no-lysine (WNK) kinases were identified as the genes responsible for the human hereditary hypertensive disease pseudohypoaldosteronism type II (PHAII). It took a further 6 years to clarify that WNK kinases participate in a signaling cascade with oxidative stress-responsive gene 1 (OSR1), Ste20-related proline-alanine-rich kinase (SPAK), and thiazide-sensitive NaCl cotransporter (NCC) in the kidney and the constitutive activation of this signaling cascade is the molecular basis of PHAII. Since this discovery, the WNK-OSR1/SPAK-NCC signaling cascade has been shown to be involved not only in PHAII but also in the regulation of blood pressure under normal and pathogenic conditions, such as hyperinsulinemia. However, the molecular mechanisms of WNK kinase regulation by dietary and hormonal factors and by PHAII-causing mutations remain poorly understood. In 2012, two additional genes responsible for PHAII, Kelch-like 3 (KLHL3) and Cullin3, were identified. At the time of their discovery, the molecular mechanisms underlying the interaction between these genes and their involvement in PHAII were unknown. Here we review the pathophysiological roles of the WNK signaling cascade clarified to date and introduce a new mechanism of WNK kinase regulation by KLHL3 and Cullin3, which provides insight on previously unknown mechanisms of WNK kinase regulation.
Insights
Pseudohypoaldosteronism type II (PHAII) is linked to WNK kinases. New research reveals KLHL3 and Cullin3 regulate WNK kinases, offering insights into PHAII and blood pressure control.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Pseudohypoaldosteronism type II (PHAII) is a hereditary hypertensive disease linked to With-no-lysine (WNK) kinases.
- The WNK-OSR1/SPAK-NCC signaling cascade regulates blood pressure but its regulation mechanisms are poorly understood.
- KLHL3 and Cullin3 were identified as PHAII genes, but their roles were initially unclear.
Purpose of the Study:
- To review the pathophysiological roles of the WNK signaling cascade.
- To introduce a novel mechanism of WNK kinase regulation by KLHL3 and Cullin3.
- To provide insights into the molecular mechanisms of WNK kinase regulation in PHAII.
Main Methods:
- Literature review of WNK kinase signaling and PHAII.
- Analysis of the interaction between KLHL3, Cullin3, and WNK kinases.
- Discussion of the implications for blood pressure regulation.
Main Results:
- The WNK-OSR1/SPAK-NCC signaling cascade is crucial for blood pressure regulation.
- KLHL3 and Cullin3 form a complex that regulates WNK kinase activity.
- This interaction provides a new understanding of WNK kinase regulation.
Conclusions:
- The KLHL3-Cullin3 complex represents a key regulatory mechanism for WNK kinases.
- Understanding this pathway is vital for PHAII and blood pressure disorders.
- Further research into WNK kinase regulation can uncover new therapeutic targets.
Related Concept Videos
Cell Signaling in Plants
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
PI3K/mTOR/AKT Signaling Pathway

